ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,498,567 | +180.1% | 156,946 | +391.2% | 0.44% | +578.5% |
| Q1 2022 | $2,320,000 | +73.8% | 31,952 | +128.2% | 0.06% | +35.4% |
| Q2 2021 | $1,335,000 | -79.9% | 14,000 | -76.0% | 0.05% | -71.1% |
| Q1 2021 | $6,638,000 | -55.0% | 58,300 | -45.3% | 0.17% | -40.9% |
| Q4 2020 | $14,756,000 | – | 106,600 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
| CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
| Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
| Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
| Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
| Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
| Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
| Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
| ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |